Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

KaloBios Pharmaceuticals Inc (NASDAQ:KBIO)

2.09
Delayed Data
As of Aug 04
 0.00 / 0.00%
Today’s Change
1.98
Today|||52-Week Range
17.20
-84.90%
Year-to-Date
No recent news for KaloBios Pharmaceuticals Inc.

Today’s Trading

Previous close2.09
Today’s open2.05
Day’s range1.98 - 2.10
Volume29,517
Average volume (3 months)80,194
Market cap$8.6M
Dividend yield--
Data as of 3:59pm ET, 08/04/2015

Growth & Valuation

Earnings growth (last year)+33.53%
Earnings growth (this year)+29.57%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book0.35

Competitors

 Today’s
change
Today’s
% change
CDXICardax Inc0.000.00%
CPHIChina Pharma Holding...-0.03-11.47%
RCPIRock Creek Pharmaceu...-0.03-2.54%
SGYPUSynergy Pharmaceutic...0.000.00%
Data as of 3:59pm ET, 08/04/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$1.68
Annual revenue (last year)$0.00
Annual profit (last year)-$38.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive &
Financial Officer
Herbert C. Cross
Chief Scientific Officer
Geoffrey Thomas Yarranton
Corporate headquarters
South San Francisco, California

Forecasts